Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -161.15%-27.16B | -51.30%44.42B | 42.91%91.21B | 209.05%63.82B | -86.09%-58.53B | 51.91%-31.45B | 27.86%-65.4B | -180.88%-90.66B | -250.90%-32.28B | 200.60%21.39B |
Net profit before non-cash adjustment | -24.49%18.04B | -18.69%23.89B | 24.78%29.38B | -6.75%23.54B | 61.19%25.25B | -50.42%15.66B | -7.37%31.59B | 16.13%34.1B | 46.15%29.36B | -25.26%20.09B |
Total adjustment of non-cash items | -6.13%33.14B | 14.67%35.31B | -8.34%30.79B | 6.42%33.59B | 2.39%31.57B | 122.13%30.83B | 5.22%13.88B | -17.58%13.19B | -28.79%16B | -10.77%22.47B |
-Depreciation and amortization | -17.53%21.9B | 4.50%26.55B | 6.26%25.41B | 7.20%23.91B | 36.38%22.3B | 182.16%16.35B | -13.36%5.8B | -8.78%6.69B | -31.85%7.33B | -11.71%10.76B |
-Reversal of impairment losses recognized in profit and loss | --1.18B | --0 | ---- | --28M | ---- | -10.61%177M | --198M | ---- | ---- | ---- |
-Disposal profit | 2,091.89%811M | 2.78%37M | -44.62%36M | -79.69%65M | -94.38%320M | 7,589.19%5.69B | 150.00%74M | -3.50%-148M | 48.56%-143M | -47.87%-278M |
-Pension and employee benefit expenses | ---141M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 7.78%9.4B | 63.03%8.72B | -44.24%5.35B | 7.25%9.59B | 3.89%8.94B | 10.20%8.61B | 17.48%7.81B | -24.55%6.65B | -26.50%8.81B | -9.06%11.99B |
Changes in working capital | -430.12%-78.34B | -147.60%-14.78B | 364.08%31.04B | 105.80%6.69B | -47.98%-115.34B | 29.70%-77.95B | 19.63%-110.88B | -77.68%-137.95B | -266.67%-77.64B | 71.13%-21.17B |
-Change in receivables | -582.88%-98.4B | -120.83%-14.41B | 41.97%69.19B | 219.33%48.74B | -160.39%-40.84B | 470.25%67.63B | 115.28%11.86B | 29.86%-77.61B | 3.36%-110.65B | 54.71%-114.5B |
-Change in inventory | -161.11%-1.69B | 42.11%2.76B | 615.07%1.95B | -80.19%272M | 223.82%1.37B | 1,596.00%424M | 111.47%25M | 16.79%-218M | -227.80%-262M | -78.14%205M |
-Change in payables | 617.80%57.42B | 73.51%-11.09B | -162.10%-41.86B | 78.68%-15.97B | 30.57%-74.91B | -66.49%-107.89B | -429.04%-64.8B | -116.89%-12.25B | -48.18%72.5B | -39.08%139.91B |
-Provision for loans, leases and other losses | 112.94%1.02B | 13.90%-7.88B | -14.97%-9.15B | -126.54%-7.96B | -709.22%-3.51B | 46.75%-434M | 78.82%-815M | -35.40%-3.85B | 73.57%-2.84B | 65.12%-10.75B |
-Changes in other current assets | -376.27%-30.59B | 24.92%11.07B | 252.58%8.87B | 86.79%-5.81B | 8.40%-43.97B | 31.12%-48.01B | -46.78%-69.7B | 0.08%-47.48B | -84.94%-47.52B | 10.03%-25.7B |
-Changes in other current liabilities | -227.90%-6.09B | 132.42%4.76B | 116.28%2.05B | -127.05%-12.58B | 350.23%46.52B | -17.71%10.33B | 263.31%12.56B | -68.96%3.46B | 207.70%11.14B | -225.43%-10.34B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -45.95%-13.26B | -3.60%-9.08B | -6.34%-8.77B | 0.45%-8.25B | -0.58%-8.28B | -6.80%-8.23B | -2.04%-7.71B | 16.65%-7.56B | 26.46%-9.07B | 8.17%-12.33B |
Interest received (cash flow from operating activities) | -21.25%1.02B | -20.21%1.3B | 51.16%1.63B | 18.48%1.08B | -13.92%909M | 83.02%1.06B | 46.82%577M | 4.24%393M | -20.80%377M | 52.56%476M |
Tax refund paid | 2.23%-4.33B | -91.53%-4.43B | -11.47%-2.31B | 17.82%-2.08B | 18.39%-2.53B | 39.29%-3.09B | 25.90%-5.1B | -423.36%-6.88B | -5.12%-1.31B | -226.37%-1.25B |
Other operating cash inflow (outflow) | 26,500.00%264M | 0.00%-1M | -1M | 0 | 1.65B | 0 | -1M | 0 | 0.00%-1M | -1M |
Operating cash flow | -234.98%-43.47B | -60.61%32.2B | 49.79%81.76B | 181.74%54.58B | -60.04%-66.77B | 46.26%-41.72B | 25.85%-77.63B | -147.63%-104.7B | -610.12%-42.28B | 123.85%8.29B |
Investing cash flow | ||||||||||
Capital expenditures | ---- | ---- | ---- | 16.08%-12.84B | 33.63%-15.3B | 10.38%-23.05B | 2.10%-25.72B | -26.30%-26.27B | -21.22%-20.8B | -3.57%-17.16B |
Net PPE purchase and sale | -2.90%-13.5B | -6.46%-13.12B | ---12.32B | --0 | 206.16%6.51B | 6,152.94%2.13B | --34M | ---- | ---- | ---- |
Net business purchase and sale | ---23.88B | --0 | 451.02%1.38B | ---394M | ---- | 122.14%536M | ---2.42B | ---- | ---- | ---- |
Net investment product transactions | 43.80%-4.8B | -47,522.22%-8.54B | 120.45%18M | 90.53%-88M | -1,551.56%-929M | -89.61%64M | -51.65%616M | 695.33%1.27B | -101.20%-214M | 231.06%17.9B |
Advance cash and loans provided to other parties | ---4.6B | --0 | -72.22%-6.2B | -9.09%-3.6B | 49.23%-3.3B | -8.33%-6.5B | -150.00%-6B | ---2.4B | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | 24.20%4.85B | 29.43%3.9B | -35.13%3.01B | 64.58%4.65B | 67.04%2.82B | --1.69B | ---- | ---- | ---- | ---- |
Net changes in other investments | 0.81%-2.56B | 47.43%-2.58B | -183.58%-4.91B | 15.36%-1.73B | 11.97%-2.04B | 25.74%-2.32B | -449.56%-3.13B | 60.01%-569M | -2.08%-1.42B | -65.56%-1.39B |
Investing cash flow | -118.78%-44.48B | -6.94%-20.33B | -35.79%-19.01B | -14.43%-14B | 55.43%-12.24B | 25.02%-27.45B | -30.94%-36.61B | -24.64%-27.96B | -3,362.04%-22.43B | 97.87%-648M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 405.86%228.94B | -492.41%-74.85B | -118.87%-12.64B | -13.56%66.95B | -55.84%77.45B | -26.66%175.39B | 56.02%239.14B | 32.49%153.27B | 2,099.75%115.69B | -87.04%5.26B |
Net common stock issuance | 96.19%-8M | ---210M | --0 | ---153M | --0 | --0 | ---269M | --0 | ---- | ---- |
Net preferred stock issuance | ---- | ---- | -33.32%-21.36B | -0.02%-16.02B | 24.01%-16.02B | 71.08%-21.08B | ---72.89B | ---- | ---- | ---- |
Increase or decrease of lease financing | 1.35%-437M | -3.26%-443M | 5.51%-429M | 40.11%-454M | 21.94%-758M | 11.81%-971M | -31.54%-1.1B | 78.33%-837M | 5.41%-3.86B | -1.64%-4.08B |
Cash dividends paid | -32.82%-6.87B | 9.68%-5.17B | 6.93%-5.73B | -26.46%-6.15B | 3.13%-4.86B | -0.02%-5.02B | ---5.02B | ---- | ---- | ---- |
Net other fund-raising expenses | 0.00%-1M | 0.00%-1M | -200.00%-1M | -94.12%1M | 950.00%17M | -101.35%-2M | 970.59%148M | 51.43%-17M | 30.00%-35M | 47.92%-50M |
Financing cash flow | 374.71%221.63B | -100.94%-80.68B | -190.89%-40.15B | -20.88%44.17B | -62.36%55.83B | -7.31%148.32B | 4.98%160.01B | 36.35%152.42B | 9,836.62%111.79B | -96.92%1.13B |
Net cash flow | ||||||||||
Beginning cash position | -16.74%339.84B | 5.97%408.19B | 28.27%385.18B | -7.15%300.28B | 32.42%323.42B | 23.04%244.24B | 11.02%198.5B | 35.47%178.79B | 7.19%131.98B | -18.26%123.13B |
Current changes in cash | 294.28%133.68B | -404.54%-68.81B | -73.34%22.59B | 465.66%84.75B | -129.29%-23.18B | 72.94%79.14B | 131.58%45.76B | -58.02%19.76B | 437.07%47.07B | 130.54%8.77B |
Effect of exchange rate changes | 1.94%473M | 11.00%464M | 194.37%418M | 230.23%142M | 34.38%43M | 252.38%32M | 61.11%-21M | 79.47%-54M | -405.81%-263M | -92.79%86M |
Cash adjustments other than cash changes | --5.36B | ---- | -133.33%-1M | 400.00%3M | ---1M | ---- | ---- | 50.00%-1M | -300.00%-2M | --1M |
End cash Position | 41.05%479.36B | -16.74%339.84B | 5.97%408.19B | 28.27%385.18B | -7.15%300.28B | 32.42%323.42B | 23.04%244.24B | 11.02%198.5B | 35.47%178.79B | 7.19%131.98B |
Free cash flow | -399.64%-57.13B | -72.37%19.07B | 65.31%69.01B | 150.87%41.74B | -26.71%-82.07B | 37.33%-64.77B | 21.09%-103.35B | -107.63%-130.96B | -611.28%-63.08B | 82.72%-8.87B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |